While Prempro may cure your hot flashes, it may also debilitate or kill you from ovarian cancer, breast cancer, endometrial cancer, and stroke.
Since 1995, millions of women have confidently taken Prempro, a leading hormone replacement therapy drug, prescribed to treat postmenopausal hot flashes and other menopausal symptoms.
However, a recent major study concludes that long-term use of Prempro has significantly increased the risk of stroke, blood clots, Prempro ovarian cancer, endometrial cancer, and breast cancer, while maximizing the risk for dementia and Alzheimer’s disease. Evidence has revealed that Prempro and other estrogen progestin combinations can actually harm perfectly healthy women.
These results were found in the nation's largest hormone replacement study and were so alarming that the National Institute of Health (NIH) prematurely canceled the study citing risk to the participants. As a result the study is suggesting that many of the women who use Prempro and other estrogen and progestin combinations should quit and talk to their doctors about Prempro alternatives.
Prempro is manufactured by Wyeth Pharmaceuticals. In 2001 Prempro accounted for approximately $890 million of the company's $13.9 billion in sales.
Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.
See: http://www.monheit.com/prempro/problem.shtml for the original text of this article.
Zyprexa Lawsuits
Zyprexa litigation has been targeted at a number of Zyprexa side-effect problems: Some patients have reported the Zyprexa side-effect of gaining up to 65 pounds after taking Zyprexa. After the weight gain some developed the Zyprexa side-effect of diabetes or glucose abnormalities. Patients who already had the Zyprexa side-effect of theit diabetes growing worse while taking Zyprexa. Worse yet -- patients died from developing diabetes. These patients were never treated for diabetes and didn’t know they had diabetes. Patients under 54 years old, face the highest risk of developing the Zyprexa side-effect of diabetes or having heart attacks and comas when taking Zyprexa.
Zyprexa Settlement - $690,000,000
Eli and Lilly Company stock moved little Friday after Thursday night's announcement of a whopping $690 million Zyprexa settlement. Plaintiff lawyers and Eli Lilly and Co. late on June 9 announced an agreement in principle to settle a majority of Zyprexa claims for $690 million.
Side Effects of Prempro - Who is Responsible for them?
Who is responsible for damages from the side-effects of Prempro?
